Post by
narcissist on Sep 08, 2011 10:10am
psoriasis news
This is a significant survey result. Study is posted here:
https://www.marketwatch.com/story/at-least-one-half-of-surveyed-european-dermatologists-say-they-are-likely-to-delay-their-prescribing-of-tofacitinib-until-it-has-accumulated-favorable-postmarketing-safety-data-2011-09-08
"The new European Physician & Payer Forum report entitled European Physician and Payer Perspectives on Emerging Immunomodulators in Psoriasis also finds that the majority of surveyed dermatologists in the EU5 indicate that they will prescribe Isotechnika's emerging calcinuerin inhibitor voclosporin, following its launch for psoriasis."